Jessica Lee

Targeting TORC1/2 enhances sensitivity to EGFR inhibitors in head and neck cancer preclinical models.

Lin Wang, J. Grandis, S. Thomas, 2012, Neoplasia.

Microbiomic differences at cancer-prone oral mucosa sites with marijuana usage

G. Adami, Jessica Lee, T. Newman, 2019, Scientific Reports.

First-in-human trial of a STAT3 decoy oligonucleotide in head and neck tumors: implications for cancer therapy.

Simion I. Chiosea, Joanne I. Yeh, D. Ly, 2012, Cancer discovery.

First-inHuman Trial of a STAT 3 Decoy Oligonucleotide in Head and Neck Tumors : Implications for Cancer Therapy

Simion I. Chiosea, Joanne I. Yeh, D. Ly, 2012 .